-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on DarioHealth, Lowers Price Target to $5

Benzinga·11/13/2026 13:04:09
Stifel analyst David Grossman maintains DarioHealth (NASDAQ:DRIO) with a Buy and lowers the price target from $10 to $5.